Implantes mamarios en tiempos de linfoma y COVID-19. ¿Han aumentado las complicaciones?

EMC - Cirugía Plástica Reparadora y Estética Pub Date : 2023-01-01 DOI:10.35366/113275

Estela Vélez-Benítez, Jesús Cuenca-Pardo, Bertha Torres-Gómez, Arturo Ramírez-Montañana, Raúl Alfonso Vallarta-Rodríguez, Rufino Iribarren-Moreno, Guillermo Ramos-Gallardo, Martín de la Cruz Lira-Álvarez

{"title":"Implantes mamarios en tiempos de linfoma y COVID-19. ¿Han aumentado las complicaciones?","authors":"Estela Vélez-Benítez, Jesús Cuenca-Pardo, Bertha Torres-Gómez, Arturo Ramírez-Montañana, Raúl Alfonso Vallarta-Rodríguez, Rufino Iribarren-Moreno, Guillermo Ramos-Gallardo, Martín de la Cruz Lira-Álvarez","doi":"10.35366/113275","DOIUrl":null,"url":null,"abstract":". ABSTRACT Breast implant-associated lymphoma (BIA-ALCL) has been linked to macro-textured shells, which has caused most surgeons to no longer place textured implants. COVID-19 and the vaccines cause the activation of the immune system, including immunologically active cells such as macrophages, T lymphocytes and myofibroblasts that are found around breast implants, with inflammatory reactions, which have been associated with an increase in surgical complications of breast implants. We carried out a survey among the members of the Mexican Association of Plastic, Aesthetic and Reconstructive Surgery, to identify the impact that the COVID-19 pandemic and lymphoma (BIA-ALCL) has had on breast augmentation surgery with implants. 456 associates participated, which represent a very significant sample. Most are applying smooth or nano or microtextured implants; there is a marked tendency to stop using textured implants. The pandemic had a minimal effect on the frequency of breast augmentation surgery with implants and complications. Most","PeriodicalId":100417,"journal":{"name":"EMC - Cirugía Plástica Reparadora y Estética","volume":"234 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"EMC - Cirugía Plástica Reparadora y Estética","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35366/113275","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

. ABSTRACT Breast implant-associated lymphoma (BIA-ALCL) has been linked to macro-textured shells, which has caused most surgeons to no longer place textured implants. COVID-19 and the vaccines cause the activation of the immune system, including immunologically active cells such as macrophages, T lymphocytes and myofibroblasts that are found around breast implants, with inflammatory reactions, which have been associated with an increase in surgical complications of breast implants. We carried out a survey among the members of the Mexican Association of Plastic, Aesthetic and Reconstructive Surgery, to identify the impact that the COVID-19 pandemic and lymphoma (BIA-ALCL) has had on breast augmentation surgery with implants. 456 associates participated, which represent a very significant sample. Most are applying smooth or nano or microtextured implants; there is a marked tendency to stop using textured implants. The pandemic had a minimal effect on the frequency of breast augmentation surgery with implants and complications. Most

查看原文本刊更多论文

淋巴瘤和COVID-19时期的乳房植入物。并发症增加了吗?

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

EMC - Cirugía Plástica Reparadora y Estética

自引率

0.00%

发文量